TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

Supply agreement SARS-CoV-2 mRNA Vaccine

Vaccines
UK
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: Business Energy and Industrial Strategy: "Supply agreement SARS-CoV-2 mRNA Vaccine". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityBusiness Energy and Industrial StrategyScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: Business Energy and Industrial Strategy
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for Business Energy and Industrial Strategy. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
2.1Bids / Report
64% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 26 active published awards; 25 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityBusiness Energy and Industrial Strategy
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSNot published
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published20 May 2021, 16:21 BST
Last source update20 May 2021, 16:21 BST
Recurring procurementNot published
ClassificationVaccines
Delivery area
UK
OCIDocds-h6vhtk-02b35e
What is being bought
The procurement of the mRNA-1273 vaccine.
What changed
From the official release history
  1. Status changed to complete
    20 May 2021, 16:21 BST
  2. Official notice release published
    20 May 2021, 16:21 BST
  3. Buyer information updated
    20 May 2021, 16:21 BST
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    cancelled
    Published valueNot published
    The procurement of the mRNA-1273 vaccine. Additional information: Contract value is being withheld due to commercial sensitivity (Reg 50(6)(b) and (c)). Publication may enable competitors to calculate cost per dose. This will commercially prejudice: (i) the supplier in its negotiations with other national governments; and (ii) the contracting authority in negotiations with other vaccine vendors. It may also impact fair competition between vaccine vendors.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    20 May 2021, 16:21 BST
  2. Award active
    Not published · Not published
  3. Contract active
    Signed 31 Dec 2020, 00:00 GMT · £1
Commercial outcome and competition
Awards
Moderna Switzerland GmbH
Not published · Not published · active
Contracts
Supply Agreement SARS-CoV-2 mRNA Vaccine
£1 · signed 31 Dec 2020, 00:00 GMT · active
Bid statistics
bids: 1 (lot 1)
Buyer and organisations in this procedure

Business Energy and Industrial Strategy

Contracting authority GB-FTS-5606
View buyer profile

  • Business Energy and Industrial Strategy
    buyer

    1 Victoria Street, London, UK, SW1H0ET
    VTFContracts@beis.gov.uk

  • Department of Business, Energy and Industrial Strategy
    reviewBody

    1 Victoria Street, Westminister, London, SW1H 0ET

  • Moderna Switzerland GmbH
    supplier

    Aeschenvorstadt 48,, Basel, CH, 4051
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published
Planning and rationale
Planning budgetNot published
No-engagement rationaleNot published
Procedure rationaleThe award of the contract to Moderna is strictly necessary for unforeseeable reasons of extreme urgency; i.e. the urgent requirement to find a viable vaccine to end the Covid-19 pandemic (Regulation 32(2)(c)).